MedTrace Logo

Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease

NCT01583595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2013-04-04

No results posted yet for this study

Summary

Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate).

Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Roberto P Benzo, M.D., MSc · Mayo Clinic

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01583595 on ClinicalTrials.gov